A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors

A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors

Objective: For early-stage cervical cancer patients experiencing radical surgery, postoperative radiotherapy was recommended for patients with a combination of intermediate-risk factors. However, there was no consensus on whether to administer concurrent chemotherapy. The aim of the study was to con...

Full description

Bibliographic Details
Main Authors: Chunli Fu, Cong Wang, Qiuhong Qian, Youzhong Zhang, Changdong Ma, Li Miao, Guangyu Zhang
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Gynecologic Oncology Reports
Subjects:
Cervical Cancer
Radiotherapy
Concurrent Chemotherapy
COUNT Score
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578923000978

Similar Items

Similar Items